Inge M. Zomerdijk

Senior Pharmacovigilance assessor
Department of Pharmacovigilance, Medicines Evaluation Board, Utrecht, The Netherlands., United States

Inge Zomerdijk completed her PhD at the Erasmus University Medical Center. Her research was in the field of risk management, risk minimization measures, measuring effectiveness of risk minimization measures and pharmacoepidemiology. Currently, she is a senior pharmacovigilance assessor at the Medicines Evaluation Board. She is involved in research projects on risk minimization.

Disclosure information not submitted.

Presentation(s):

• OP4-3 - Description of the delay in completion of studies that evaluate the effectiveness of additional risk minimization measures

  Tuesday, April 25, 2023
  4:00 PM – 5:30 PM GMT